Info: Read More
  • 中药标准品生产商,产品定制服务
  • 隐丹参酮


    产品编号 CFN98478
    CAS编号 35825-57-1
    分子式 = 分子量 C19H20O3 = 296.4
    产品纯度 >=98%
    物理属性 Red powder
    化合物类型 Diterpenoids
    植物来源 The roots of Salvia miltiorrhiza Bge.
    产品名称 产品编号 CAS编号 包装 QQ客服
    隐丹参酮 CFN98478 35825-57-1 10mg QQ客服:1413575084
    隐丹参酮 CFN98478 35825-57-1 20mg QQ客服:1413575084
    隐丹参酮 CFN98478 35825-57-1 50mg QQ客服:1413575084
    隐丹参酮 CFN98478 35825-57-1 100mg QQ客服:1413575084
    1. 在您收到产品后请检查产品。如无问题,请将产品存入冰霜并且样品瓶保持密封,产品可以存放长达24个月(2-8摄氏度)。

    2. 只要有可能,产品溶解后,您应该在同一天应用于您的实验。 但是,如果您需要提前做预实验,或者需要全部溶解,我们建议您将溶液以等分试样的形式存放在-20℃的密封小瓶中。 通常,这些可用于长达两周。 使用前,打开样品瓶前,我们建议您将产品平衡至室温至少1小时。

    3. 需要更多关于溶解度,使用和处理的建议? 请发送电子邮件至
  • 1. 在线订购
  • 请联系我们QQ客服

  • 2. 电话订购
  • 请拨打电话:
    027-84237683 或 027-84237783

  • 3. 邮件或传真订购
  • 发送电子邮件到: 或

  • 提供订购信息
  • 为了方便客户的订购,请需要订购ChemFaces产品的客户,在下单的时候请提供下列信息,以供我们快速为您建立发货信息。
  • 1. 产品编号(CAS No.或产品名称)
  • 2. 发货地址
  • 3. 联系方法 (联系人,电话)
  • 4. 开票抬头 (如果需要发票的客户)
  • 5. 发票地址(发货地址与发票地址不同)
  • 发货时间
    1. 付款方式为100%预付款客户,我们将在确认收到货款后当天或1-3个工作日发货。

    2. 付款方式为月结的客户,我们承诺在收到订单后当天或1-3个工作日内发货。

    3. 如果客户所需要的产品,需要重新生产,我们有权告知客户,交货时间需要延期。

    Cell. 2018 Jan 11;172(1-2):249-261.e12.
    doi: 10.1016/j.cell.2017.12.019.

    PMID: 29328914

    Cell Metab. 2020 Mar 3;31(3):534-548.e5.
    doi: 10.1016/j.cmet.2020.01.002.

    PMID: 32004475

    Mol Cell. 2017 Nov 16;68(4):673-685.e6.
    doi: 10.1016/j.molcel.2017.10.022.

    PMID: 29149595

    ACS Nano. 2018 Apr 24;12(4): 3385-3396.
    doi: 10.1021/acsnano.7b08969.

    PMID: 29553709

    Nature Plants. 2016 Dec 22;3: 16206.
    doi: 10.1038/nplants.2016.205.

    PMID: 28005066

    Sci Adv. 2018 Oct 24;4(10): eaat6994.
    doi: 10.1126/sciadv.aat6994.

    PMID: 30417089
  • University of Limpopo (South Africa)
  • Instituto de Investigaciones Agropecuarias (Chile)
  • Uniwersytet Gdański (Poland)
  • Sanford Burnham Medical Research Institute (USA)
  • Cancer Research Initatives Foundation(CARIF) (Malaysia)
  • Almansora University (Egypt)
  • Deutsches Krebsforschungszentrum (Germany)
  • Shanghai Institute of Biochemistry and Cell Biology (China)
  • University Medical Center Mainz (Germany)
  • Wageningen University (Netherlands)
  • University of Vienna (Austria)
  • Copenhagen University (Denmark)
  • Universidad de Antioquia (Colombia)
  • China Medical University (Taiwan)
  • More...
  • 国外学术期刊发表的引用ChemFaces产品的部分文献
  • Korean J Pain.2021, 34(4):405-416.
  • Evid Based Complement Alternat Med.2021, 2021:5023536.
  • Vietnam Journal of Science2022,64(2):69-75.
  • Molecules.2021, 26(6):1635.
  • Int J Mol Sci.2022, 23(5):2796.
  • Phytomedicine.2022, 99:154025.
  • Agronomy 2021, 11(3),502.
  • Planta Med.2022, 88(9-10):794-804.
  • J Cell Mol Med.2022, 26(23):5807-5819.
  • Molecules.2021, 26(9):2791.
  • Front Neurosci.2019, 13:1091
  • Applied Biological Chemistry 2022, 65,5(2022).
  • J Sep Sci.2018, 41(7):1682-1690
  • Analytical Methods2018, 10(27)
  • J Nat Med.2017, 71(4):745-756
  • Oxid Med Cell Longev.2021, 2021:6647107.
  • Molecules.2016, 21(10)
  • Planta Med.2016, 82(13):1208-16
  • Sci Rep. 2018, 1-9
  • Front Pharmacol.2018, 9:756
  • University of Limpopo2016, 1-237
  • Food Funct.2022, 13(14):7638-7649.
  • Antioxidants (Basel).2021, 10(8):1300.
  • ...
  • 生物活性
    Description: Cryptotanshinone is a potent STAT3 inhibitor with IC50 of 4.6 μM, and inhibits STAT3 Tyr705 phosphorylation in DU145 prostate cancer cells. It is also an AR inhibitor to suppress androgen/AR-mediated cell growth and PSA expression by blocking AR dimerization and the AR-coregulator complex formation. Cryptotanshinone has anti-atherosclerosis, neuroprotective, anti-cancer,and anti-neointimal formation activities. Cryptotanshinone reverses DEX-induced androgen excess and ovarian IR in mice through activation of insulin signaling and the regulation of glucose transporters and hormone-synthesizing enzymes, it has an inhibitory effect on MMP-9 production and migration of human aortic smooth muscle cells treated with TNF-alpha in a dose-dependent manner.
    Targets: NF-kB | TNF-α | ROS | Caspase | p38MAPK | Akt | P450 (e.g. CYP17) | JNK | MMP(e.g.TIMP) | AP-1 | Androgen Receptor | ERK | PI3K | Bcl-2/Bax | COX
    In vitro:
    Apoptosis. 2011 Jul;16(7):696-707.
    Cryptotanshinone enhances TNF-α-induced apoptosis in chronic myeloid leukemia KBM-5 cells.[Pubmed: 21519916]
    Cryptotanshinone is a biologically active compound from the root of Salvia miltiorrhiza. In the present study, we investigated the molecular mechanisms by which cryptotanshinone is in synergy with tumor necrosis factor-alpha (TNF-α) for the induction of apoptosis in human chronic myeloid leukemia (CML) KBM-5 cells.
    The co-treatment of cryptotanshinone with TNF-α reduced the viability of the cells [combination index (CI) < 1]. Concomitantly, the co-treatment of cryptotanshinone and TNF-α elicited apoptosis, manifested by enhanced the number of terminal deoxynucleotide transferase-mediated dUTP-nick-end labeling (TUNEL)-positive cells, the sub-G1 cell populations, and the activation of caspase-8 and -3, in comparison with the treatment with either drug alone. The treatment with cryptotanshinone further suppressed TNF-α-mediated expression of c-FLIP(L), Bcl-x(L), but the increased level of tBid (a caspase-8 substrate). Furthermore, cryptotanshinone activated p38 but not NF-κB in TNF-α-treated KBM-5 cells. The addition of a specific p38 MAPK inhibitor SB203580 significantly attenuated cryptotanshinone/TNF-α-induced apoptosis. The combination treatment of cryptotanshinone and TNF-α also stimulated the reactive oxygen species (ROS) generation. N-acetyl-L-cysteine (NAC, a ROS scavenger) was not only able to block cryptotanshinone/TNF-α-induced ROS production but also the activation of caspase-8 and p38 MAPK.
    Overall, our findings suggest that cryptotanshinone can sensitize TNF-α-induced apoptosis in human myeloid leukemia KBM-5 cells, which appears through ROS-dependent activation of caspase-8 and p38.
    Exp Brain Res. 2009 Feb;193(1):109-18.
    Cryptotanshinone protects primary rat cortical neurons from glutamate-induced neurotoxicity via the activation of the phosphatidylinositol 3-kinase/Akt signaling pathway.[Pubmed: 18936923]
    Excitotoxicity contributes to neuronal death and is involved in the pathogenesis of neurodegenerative disorders such as Alzheimer's disease (AD). In the present study, cryptotanshinone, an active ingredient from a Chinese plant, Salvia miltiorrhiza, was investigated to assess its neuroprotective effects against glutamate-induced toxicity in primary culture of rat cortical neurons.
    Cryptotanshinone reversed glutamate-induced neuronal toxicity, which was characterized by decreased cell viability, increased lactate dehydrogenase release, neuronal DNA condensation, and the alteration of the expression of Bcl-2 family proteins. The neuroprotective effects of cryptotanshinone could be blocked by LY294002 and wortmannin, two inhibitors of PI3K. The importance of the PI3K pathway was further confirmed by the activation of Akt and anti-apoptotic Bcl-2 by cryptotanshinone in a PI3K-dependent manner.
    These results suggest that cryptotanshinone protects primary cortical neurons from glutamate-induced neurotoxicity through the activation of PI3K/Akt pathway. Such neuroprotective effects may be of interest in AD and other neurodegenerative diseases.
    In vivo:
    Fertil Steril. 2014 Aug;102(2):589-596.e4.
    Cryptotanshinone reverses ovarian insulin resistance in mice through activation of insulin signaling and the regulation of glucose transporters and hormone synthesizing enzymes.[Pubmed: 24973798]
    To investigate the effects of cryptotanshinone (CRY), an active component of Chinese medicine, on ovarian androgen production, insulin resistance (IR), and glucose metabolism in mice.
    Animal model and in vitro tissue model. University-affiliated laboratory. Ovarian IR was induced by dexamethasone (DEX) in vivo. Animals were randomized to receive CRY treatment for 3 days or not. Ovulation rates, serum steroid levels, and glucose uptake in ovaries were quantified, and proteins in the phosphatidylinositol 3-hydroxy kinase pathway were measured. In vitro ovarian IR was also induced by DEX for 3 days. Ovarian steroid hormone secretion and glucose uptake were measured, and the hormone-synthesizing enzymes were determined by semiquantitative reverse transcription-polymerase chain reaction. Ovarian glucose uptake, in vivo ovulation rate, serum and culture medium steroid level, and molecular expression of phosphatidylinositol 3-hydroxy kinase and steroidogenic enzymes. Dexamethasone significantly increased ovulation rates in vivo and increased T and E2 production and decreased ovarian glucose uptake in vivo and in vitro. Cryptotanshinone significantly reduced ovulation rates in vivo and decreased T and estrogen production in vitro. Cryptotanshinone attenuated the inhibition of DEX on AKT2 and suppressed the up-regulation of CYP11 and CYP17 expression by DEX.
    Cryptotanshinone reversed DEX-induced androgen excess and ovarian IR in mice through activation of insulin signaling and the regulation of glucose transporters and hormone-synthesizing enzymes. This suggests a potential role for CRY in treating the ovulatory dysfunction associated with PCOS.
    Leuk Lymphoma . 2015 Mar;56(3):730-8.
    Cryptotanshinone acts synergistically with imatinib to induce apoptosis of human chronic myeloid leukemia cells[Pubmed: 24884318]
    Abstract Imatinib resistance has emerged as a significant clinical problem in chronic myeloid leukemia (CML) treatment. In this study, we investigated the effect and mechanism of combination treatment with imatinib and cryptotanshinone (CPT) in CML cells. Cotreatment with imatinib and CPT showed a significant synergistic killing effect in both imatinib sensitive and resistant CML cell lines, as well as primary CML cells. Furthermore, combination treatment induced apoptosis significantly, as indicated by increases in apoptotic cell fraction and activities of proapoptotic proteins. Subsequent studies revealed that CPT significantly inhibited Bcr/Abl protein expression, as well as phosphorylation expression levels of signal transducer and activator of transcription 3 (STAT3), mammalian target of rapamycin (mTOR) and eukaryotic translation initiation factor 4E (eIF4E), which are critical mediators of Bcr/Abl transformation. Furthermore, CPT in combination with imatinib dramatically decreased the activity of the Bcr/Abl pathway in both K562 and K562-R cells. Our results demonstrated that CPT increased imatinib-induced apoptosis in a Bcr/Abl dependent manner, suggesting a novel strategy for the treatment of CML. Keywords: Bcr/Abl pathway; CPT; imatinib resistance; synergism.
    1 mg 5 mg 10 mg 20 mg 25 mg
    1 mM 3.3738 mL 16.8691 mL 33.7382 mL 67.4764 mL 84.3455 mL
    5 mM 0.6748 mL 3.3738 mL 6.7476 mL 13.4953 mL 16.8691 mL
    10 mM 0.3374 mL 1.6869 mL 3.3738 mL 6.7476 mL 8.4345 mL
    50 mM 0.0675 mL 0.3374 mL 0.6748 mL 1.3495 mL 1.6869 mL
    100 mM 0.0337 mL 0.1687 mL 0.3374 mL 0.6748 mL 0.8435 mL
    * Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
    产品名称 产品编号 CAS编号 分子式 = 分子量 位单 联系QQ
    去氢丹参新酮; Dehydromiltirone CFN98532 116064-77-8 C19H20O2 = 282.38 5mg QQ客服:2056216494
    丹参新酮, 次丹参醌; Miltirone CFN98531 27210-57-7 C19H22O2 = 282.38 10mg QQ客服:3257982914
    1,2-二去氢隐丹参酮; 1,2-Didehydrocryptotanshinone CFN92144 891854-92-5 C19H18O3 = 294.4 5mg QQ客服:215959384
    隐丹参酮; Cryptotanshinone CFN98478 35825-57-1 C19H20O3 = 296.4 20mg QQ客服:2159513211
    Salvianan; Salvianan CFN92637 862832-46-0 C21H23NO2 = 321.4 5mg QQ客服:215959384
    Neosalvianen; Neosalvianen CFN91827 790673-00-6 C21H21NO2 = 319.4 5mg QQ客服:2056216494
    小红参醌丙; Trijuganone C CFN92780 135247-94-8 C20H20O5 = 340.4 5mg QQ客服:2159513211
    丹参醇B; Danshenol B CFN90474 189308-09-6 C22H26O4 = 354.43 5mg QQ客服:3257982914
    鼠尾草酚酮; Salviolone CFN92163 119400-86-1 C18H20O2 = 268.4 5mg QQ客服:215959384





    在线QQ: 1413575084


    ChemFaces为科学家,科研人员与企业提供快速的产品递送。我们通过瑞士SGS ISO 9001:2008质量体系认证天然化合物与对照品的研发和生产